Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Current Leases (2019 - 2025)

CorMedix (CRMD) has disclosed Current Leases for 7 consecutive years, with $853000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 407.74% to $853000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $853000.0 through Dec 2025, up 407.74% year-over-year, with the annual reading at $853000.0 for FY2025, 407.74% up from the prior year.
  • Current Leases hit $853000.0 in Q4 2025 for CorMedix, up from $579168.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $853000.0 in Q4 2025 to a low of $112323.0 in Q1 2021.
  • Historically, Current Leases has averaged $202113.3 across 5 years, with a median of $142533.0 in 2023.
  • Biggest five-year swings in Current Leases: rose 10.22% in 2022 and later soared 407.74% in 2025.
  • Year by year, Current Leases stood at $121368.0 in 2021, then grew by 11.23% to $135000.0 in 2022, then rose by 8.54% to $146531.0 in 2023, then rose by 14.65% to $168000.0 in 2024, then skyrocketed by 407.74% to $853000.0 in 2025.
  • Business Quant data shows Current Leases for CRMD at $853000.0 in Q4 2025, $579168.0 in Q3 2025, and $177172.0 in Q2 2025.